BioPharmX Corp.
(NYSE Amex Equities : BPMX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Producer Manufacturing » Miscellaneous Manufacturing
CSLCarlisle Cos., Inc. 1.19%126.973.8%$73.65m
PNRPentair Plc 0.37%32.812.9%$53.64m
YETIYETI Holdings, Inc. 5.14%23.310.0%$48.94m
CRCrane Co. 0.17%54.000.6%$31.78m
REYNReynolds Consumer Products, Inc. -0.27%29.900.0%$30.87m
WMSAdvanced Drainage Systems, Inc. 12.56%35.866.6%$21.19m
BRCBrady Corp. 6.04%47.430.9%$17.11m
LCIILCI Industries 7.90%74.585.3%$15.28m
TRSTriMas Corp. 6.22%25.091.1%$8.78m
TUPTupperware Brands Corp. 54.36%2.307.4%$5.73m
RAVNRaven Industries, Inc. 2.43%21.891.3%$5.40m
SXIStandex International Corp. 0.91%47.461.5%$3.37m
TGTredegar Corp. 3.18%15.240.9%$2.26m
BPMXBioPharmX Corp. -1.75%0.2818.8%$0.15m
CPSHCPS Technologies Corp. 1.01%1.000.1%$0.01m

Company Profile

BioPharmX Corp. is a specialty pharmaceutical company focused on developing prescription products utilizing its proprietary HyantX Topical Delivery System for dermatology indications. The HyantX delivery system is designed to stabilize and solubilize hydrophilic molecules in an anhydrous gel environment. The company was founded by James R. Pekarsky and Anja B. Krammer on August 30, 2010 and is headquartered in Campbell, CA.